Marius C. Hoener

Marius C. Hoener publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Marius C. Hoener sits on this spectrum.

Marius C. Hoener D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Marius C. Hoener sits on this spectrum.

Best Publications

• Trace Amines and Their Receptors.

  Raul R Gainetdinov;Marius C Hoener;Mark D Berry

  381
  Citations

• TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.

  Florent G. Revel;Jean-Luc Moreau;Raul R. Gainetdinov;Amyaouch Bradaia

  373
  Citations

• Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

  Lothar Lindemann;Claas Aiko Meyer;Karine Jeanneau;Amyaouch Bradaia

  364
  Citations

• Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

  Anna Rickli;Olivier D. Moning;Marius C. Hoener;Matthias E. Liechti

  356
  Citations

• A renaissance in trace amines inspired by a novel GPCR family

  Lothar Lindemann;Marius C. Hoener

  333
  Citations

• Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors.

  Lothar Lindemann;Martin Ebeling;Nicole A. Kratochwil;James R. Bunzow

  312
  Citations

• A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

  F G Revel;J-L Moreau;B Pouzet;R Mory

  295
  Citations

• The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

  Amyaouch Bradaia;Gerhard Trube;Henri Stalder;Roger D. Norcross

  251
  Citations

• Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

  L.D. Simmler;A. Rickli;M.C. Hoener;M.E. Liechti

  232
  Citations

• Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

  Evelyn Braungart;Manfred Gerlach;Peter Riederer;Ralf Baumeister

  228
  Citations

• Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

  Anna Rickli;Dino Luethi;Julian Reinisch;Danièle Buchy

  223
  Citations

• Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges.

  Mark D. Berry;Raul R. Gainetdinov;Raul R. Gainetdinov;Marius C. Hoener;Mohammed Shahid

  223
  Citations

• Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

  Anna Rickli;Marius C. Hoener;Matthias E. Liechti

  212
  Citations

• Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.

  Damiana Leo;Ilya Sukhanov;Ilya Sukhanov;Francesca Zoratto;Placido Illiano

  210
  Citations

• Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics

  Florent G. Revel;Jean-Luc Moreau;Raul R. Gainetdinov;Antonio Ferragud

  190
  Citations

• Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

  Cédric M. Hysek;Linda D. Simmler;Valentina G. Nicola;Nerina Vischer

  184
  Citations

• The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

  CM Hysek;LD Simmler;M Ineichen;E Grouzmann

  183
  Citations

• Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity-dependent neuronal plasticity.

  Oliver Griesbeck;Marco Canossa;Marco Canossa;Gabriele Campana;Gabriele Campana;Annette Gärtner

  148
  Citations

• Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors

  D. Leo;L. Mus;S. Espinoza;M.C. Hoener

  145
  Citations

• Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.

  Anja Harmeier;Stefan Obermueller;Claas A. Meyer;Florent G. Revel

  144
  Citations